LGVN CIK: 1721484

Longeveron Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−9.64
FY22:
−14.0
FY23:
−19.0
FY24:
−13.9
FY25:
−18.6
Change from FY21 to FY25
millions USD
FY21:
−10.7
FY22:
−0.68
FY23:
8.19
FY24:
−0.64
FY25:
−0.60
Change from FY21 to FY25
millions USD
FY21:
45.2
FY22:
−0.51
FY23:
5.26
FY24:
28.8
FY25:
4.67
(positive)
Change from FY21 to FY25
millions USD
FY21:
−9.97
FY22:
−14.5
FY23:
−19.3
FY24:
−14.5
FY25:
−18.9

All amounts in millions USD Data source:SEC EDGAR